Grant Submission Guidelines 2024
Detailed submission criteria including research focus, budget allocation, and personnel prerequisites for successful applications. Grant information will be posted on Proposal Central in December of 2023. Read More
$50,000 to Dana-Farber Cancer Institute for ctDNA in sarcoma
Circulating tumor DNA (ctDNA) refers to cancer cell DNA fragments in the blood. It’s also referred to as a liquid biopsy. Dr. David Shulman has been working with a team of researchers to develop the technology for early detection (in relapse scenarios) in a variety of sarcomas by identifying ctDNA before a tumor takes root. […]
$50,000 to Medical University of South Carolina to study a Ewing Sarcoma Tumor Suppressor
Dr. Casey Langdon is a young investigator with a bright idea and a smart plan for a new Ewing sarcoma basic science study. There is so much we need to learn about Ewing. Dr. Langdon will focus on a tumor suppressor called PTEN, which is frequently lost in a variety of cancers, including a portion […]
$63,500 to a Seattle Children’s Hospital Zebrafish Study
The sarcoma research team at Seattle Children’s Hospital has partnered with another researcher who specializes in heart disorders in children. Dr. Lisa Maves’ expertise, alongside the cancer biology knowledge of Dr. Beth Lawlor, will allow for a deep dive into the problem of the cardiotoxicity resulting from a particular chemotherapy used in Ewing sarcoma. Using […]
$66,000 to Osteosarcoma Research at Fred Hutchinson Cancer Center
Fred Hutch and the OHSU/Knight Cancer Research Centers are power houses in the adult cancer space. But a project focusing on a new target in osteosarcoma will use the technology and resources at these two institutions for the benefit of kids and young adults. This is such great news! The hope is to determine whether […]
$83,500 to Seattle Children’s Research Institute to explore a less toxic option for kids with Ewing Sarcoma.
Doxorubicin is known as “The Red Devil”. With its reddish tint and devastating short and long-term side effects, the nickname suits it well. The most disturbing effect of this drug is cardiotoxicity, leaving many young cancer survivors with a progressively and permanently weakened heart. When a patient is treated for Ewing Sarcoma, they receive a […]
$100K To Tackle The Most Aggressive Subtype Of Osteosarcoma
Osteosarcoma is the most common type of bone cancer, impacting between 400 and 600 children, adolescents and young adults per year in the United States. It has historically been a very complicated cancer to study, leaving many researchers and advocates bewildered and discouraged. However, in recent years there has been strong philanthropic and scientific investment […]
$75,000 funds The Sam Day Endowed Lectureship in Pediatric Oncology at Doernbecher Children’s Hospital!
The Sam Day Endowed Lectureship in Pediatric Oncology creates an opportunity for providers to learn about leading edge developments in research and the treatment of rare pediatric cancers from world class experts. Though topics will always be relevant to oncology, lectures will benefit a wide range of pediatric and young adult providers, and will stimulate […]
$150,000 Funds Two Research Projects at Seattle Children’s Hospital
Researchers at the Ben Towne Center for Childhood Cancer Research at Seattle Children’s Research Institute have made monumental progress in the treatment of childhood blood cancers with their groundbreaking CAR T-cell therapy. This is a method of removing a person’s T-cells (a type of white blood cell that is part of the immune system), and re-engineering […]
SDF Grants $85,000 To Launch Ewing Sarcoma Precision Medicine Program
The Sam Day Foundation has partnered with the Spada Pediatric Sarcoma Foundation to fund an innovative program developed by the hard work of the Beat Childhood Cancer Consortium and North Carolina’s Atrium Health, and led by Dr. Giselle Sholler. The program is designed to offer a treatment plan for kids based on their tumor profile […]
